Organization
Fundaleu
1 clinical trial
3 abstracts
Abstract
Ponatinib (PON) in patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) and the T315I mutation (mut): 4-year results from OPTIC.Org: Versiti Blood Research Institute, Division of Hematology and Oncology, Medical College of Wisconsin, Imperial College London, Royal North Shore Hospital, Singapore General Hospital, Duke-NUS Medical School,
Clinical trial
Prospective Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase Who Achieved Deep Molecular Response With Tyrosine Kinase Inhibitors in Real Life Setting in Argentina - (Argentine Stop Trial)Status: Recruiting, Estimated PCD: 2022-06-01
Abstract
SUNMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab in combination with polatuzumab vedotin vs rituximab plus gemcitabine and oxaliplatin in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.Org: MD Anderson Cancer Center, Brown University - Lifespan Cancer Institute, Hospital de Clinicas de Porto Alegre, Samsung Medical Center, Pusan National University Hospital,
Abstract
Patient perspectives on CLL treatment side effects: A sub-analysis of the VOICE survey.Org: Alfred Health, H. Lee Moffitt Cancer Center and Research Institute, Antalya Research and Training Hospital, Fundaleu, University Hospital Hradec Králové,